Call 800 665 0411 to learn about our services

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

New CSE Biotech Stock Listing - MindBio Therapeutics Corp. (CSE: MBIO)


May 4, 2023 ( Newswire) The common shares of MindBio Therapeutics Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at on the trading date.

MindBio Therapeutics Corp., through its wholly owned subsidiaries, MindBio Therapeutics Pty. Ltd. and Digital Mind Technology Pty Ltd., operates as a biotechnology company focused on creating novel and emerging treatments for mental health conditions. The Company has a notable presence in microdosing of psychedelic medicines and is advancing its drug and technology intervention protocols through clinical trials. The Company invests in research that forms the basis for developing novel and clinically proven treatments including digital technologies and interventions to treat debilitating health conditions such as depression, anxiety and other related mental health conditions.


Les actions ordinaires de MindBio Therapeutics Corp. ont ete approuvees pour etre cotees sur le CSE.

Les documents d'inscription et d'information seront disponibles sur a la date de negociation.

MindBio Therapeutics Corp., par l'intermediaire de ses filiales en propriete exclusive, MindBio Therapeutics Pty. Ltd. et Digital Mind Technology Pty Ltd., opere en tant que societe de biotechnologie axee sur la creation de traitements nouveaux et emergents pour les problemes de sante mentale. La societe a une presence notable dans le microdosage des medicaments psychedeliques et fait progresser ses protocoles d'intervention medicamenteux et technologiques par le biais d'essais cliniques. La Societe investit dans la recherche qui constitue la base du developpement de traitements nouveaux et eprouves en clinique, y compris des technologies numeriques et des interventions pour traiter des problemes de sante debilitants tels que la depression, l'anxiete et d'autres problemes de sante mentale connexes.

The Exchange is accepting Market Maker applications for MBIO. Please email:

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:

Pour toute question, pour obtenir de l'information supplementaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel a l'adresse: is a Canadian Securities Exchange (CSE) Service Provider; Cannabis stocks, Blockchain stocks, Mining, E-sports, Energy, Biotech and more...

Check out listing on the CSE service provider list. We offer discounts to CSE listed stocks!

The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004; the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets.

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits - A Leading Global Investor Website for Biotech Industry Stocks - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

Buy a biotech guest post on